Jacareubin Derivatives Increase Their Anti-Allergic Activity
Molecules · 15.05.2026 · 31 (10) · 1666
DOI: 10.3390/molecules31101666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 15.05.2026. Verfasst von Rosario Tavera-Hernández und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Anti-Allergic Agents, Xanthones. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Nacional Autónoma de México, Ministry of Sciences, Humanities, Technology and Innovation, DGAPA-PAPIIT-UNAM.
Abstract (Originalsprache)
Jacareubin (2), nujiangexanthone A, and α-mangostin display the highest anti-allergic effects among the active xantones through still not well-known mechanisms. This study investigates the SAR of jacareubin, its precursor xanthone V (1) and their peracetylated (1a and 2a), permethylated (1b and 2b) derivatives and their anti-allergic and anti-inflammatory effects. To characterize the inhibitory effect of jacareubin, 2a and 2b on the anaphylactic reaction, we first utilized in vitro models of bone marrow derived mast cells (BMMCs), determining their capacity of inhibiting the IgE/Antigen-induced degranulation, myeloperoxidase (MPO), and xanthine oxidase (XO) activation. Also, we utilized in vivo models of passive cutaneous anaphylaxis (PCA) and TPA-induced ear edema. In vitro tests showed that the compound 2b was more effective than jacareubin in the inhibition of BMMCs degranulation. Besides, in vivo models of PCA revealed that the fourth cyclized ring of jacareubin is the critical structural element for anti-allergic efficacy, as compound 1 was less effective. Additionally, hydroxyl groups were found to be essential for inhibiting MPO. Jacareubin was the only tested xanthone that directly inhibited XO, a result supported by molecular docking. Overall, jacareubin represents a promising multi-target scaffold that could be used for developing new treatments for inflammatory and allergic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City 04510, Mexico.
- Posgrado en Producción Animal, Departamento de Zootecnia, Universidad Autónoma Chapingo, Chapingo, Texcoco 56230, Mexico.
- Facultad de Química, Departamento de Biología, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
- Departamento de Farmacobiología y Centro de Investigación Sobre el Envejecimiento, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Sede Sur, Tlalpan, Mexico City 14330, Mexico.
- Laboratorio de Reprogramación Celular, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City 14269, Mexico.
ORCID-Profile: Rosario Tavera-Hernández, Jesabel Pérez-Rodríguez, Antonio Nieto-Camacho, José Pedraza-Chaverri, Francisco León, Claudia González-Espinosa, Manuel Jiménez-Estrada, Jorge Ivan Castillo-Arellano
Förderung
- Universidad Nacional Autónoma de México
- Ministry of Sciences, Humanities, Technology and Innovation
- DGAPA-PAPIIT-UNAM
- Secihti
Zitieren
APA
Tavera-Hernández, R., Pérez-Rodríguez, J., Nieto-Camacho, A., Medina-Campos, O. N., Pedraza-Chaverri, J., León, F., González-Espinosa, C., Jiménez-Estrada, M., Reyes-Chilpa, R., & Castillo-Arellano, J. I. (2026). Jacareubin Derivatives Increase Their Anti-Allergic Activity. Molecules, 31(10), 1666. https://doi.org/10.3390/molecules31101666
Vancouver
Tavera-Hernández R, Pérez-Rodríguez J, Nieto-Camacho A, Medina-Campos ON, Pedraza-Chaverri J, León F, et al. Jacareubin Derivatives Increase Their Anti-Allergic Activity. Molecules. 2026;31(10):1666. doi:10.3390/molecules31101666
BibTeX
@article{TaveraHernndez2026,
author = {Tavera-Hernández, Rosario and Pérez-Rodríguez, Jesabel and Nieto-Camacho, Antonio and Medina-Campos, Omar Noel and Pedraza-Chaverri, José and León, Francisco and González-Espinosa, Claudia and Jiménez-Estrada, Manuel and Reyes-Chilpa, Ricardo and Castillo-Arellano, Jorge Ivan},
title = {Jacareubin Derivatives Increase Their Anti-Allergic Activity},
journal = {Molecules},
year = {2026},
volume = {31},
number = {10},
pages = {1666},
doi = {10.3390/molecules31101666}
}
EUVIMED